Duos Technologies Group, Inc. (DUOT)
NASDAQ: DUOT · Real-Time Price · USD
6.47
-0.54 (-7.64%)
Aug 7, 2025, 4:00 PM - Market closed
Theseus Pharmaceuticals Stock Forecast
Stock Price Forecast
The 2 analysts that cover Theseus Pharmaceuticals stock have a consensus rating of "Strong Buy" and an average price target of $12.5, which forecasts a 93.35% increase in the stock price over the next year. The lowest target is $11 and the highest is $14.
Price Target: $12.50 (+93.35%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Jun 16, 2025.
Analyst Ratings
The average analyst rating for Theseus Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $9 → $11 | Strong Buy | Maintains | $9 → $11 | +70.15% | Jun 16, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $7.5 → $9 | Strong Buy | Maintains | $7.5 → $9 | +39.21% | Apr 28, 2025 |
| Northland Capital Markets | Northland Capital Markets | Buy Maintains $10 → $14 | Buy | Maintains | $10 → $14 | +116.55% | Feb 5, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $6 → $7.5 | Strong Buy | Maintains | $6 → $7.5 | +16.01% | Dec 17, 2024 |
| Northland Capital Markets | Northland Capital Markets | Buy Maintains $5.5 → $10 | Buy | Maintains | $5.5 → $10 | +54.68% | Nov 22, 2024 |
Financial Forecast
Revenue This Year
28.71M
from 7.28M
Increased by 294.36%
Revenue Next Year
41.31M
from 28.71M
Increased by 43.87%
EPS This Year
-0.53
from -1.39
EPS Next Year
0.03
from -0.53
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 |
|---|---|---|
| High | 29.7M | 48.3M |
| Avg | 28.7M | 41.3M |
| Low | 27.4M | 34.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 |
|---|---|---|
| High | 308.1% | 68.2% |
| Avg | 294.4% | 43.9% |
| Low | 276.9% | 19.5% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | -0.40 | 0.11 |
| Avg | -0.53 | 0.03 |
| Low | -0.65 | -0.04 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.